Four years after mega IPO, Circassia set for small-cap exchange

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Dec 11, 2018 at 10:32 AM.

  1. #1 cafead, Dec 11, 2018 at 10:32 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,990
    Likes Received:
    3
    via Four years ago, Circassia looked to have ushered in a new era for biotech IPOs on the London Stock Exchange when it raised £200 million ($252 million) to finance development of anti-allergy drugs. Today, Circassia is set to limp away from the main London stock exchange to take up a spot on the AIM sub-market having failed to live up to expectations as a company or as a harbinger of change.

    article source
     
    Quote

Reply to Thread